Skip to content

Clinical trials

Terminated Schizophrenia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Status: Terminated Country / region: United States Clear all

133 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20032
20041
20057
20067
20078
20087
20098
20105
20118
20128
201310
20143
20153
20166
20178
20186
201911
20204
20211
20227
20234
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated133

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Mental Health (NIMH)9
Otsuka Pharmaceutical Development & Commercialization, Inc.6
Yale University5
Denovo Biopharma LLC4
Northwestern University4
AbbVie3
Amgen3
New York State Psychiatric Institute3
Pfizer3
Shire3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia133
Psychotic Disorders43
Bipolar Disorder7
Hallucinations6
Mental Disorders6
Cognitive Dysfunction4
Obesity4
Major Depressive Disorder3
Diabetes Mellitus2
Marijuana Abuse2

Trials

Showing 1 to 25 of 133. Each trial links to its page on Pharma Observatory.

33 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.